Charmacy Pharmaceutical Co (HKSE:02289) ROCE % : 18.50% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Charmacy Pharmaceutical Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 18.50%.

Charmacy Pharmaceutical Co ROCE % Historical Data

The historical data trend for Charmacy Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co ROCE % Chart

Charmacy Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.18

14.12

12.20

24.68

17.28

Charmacy Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial														6.29	14.02	36.45	17.16	18.50

Charmacy Pharmaceutical Co ROCE % Calculation

Charmacy Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	118.358	/	( ( (3201.024 - 2518.848)	+	(3552.218 - 2864.452) )	/ 2 )
	=	118.358	/	( (682.176	+	687.766)	/ 2 )
	=	118.358	/	684.971
	=	17.28 %

Charmacy Pharmaceutical Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	123.076	/	( ( (3098.862 - 2456.317)	+	(3552.218 - 2864.452) )	/ 2 )
	=	123.076	/	( ( 642.545	+	687.766 )	/ 2 )
	=	123.076	/	665.1555
	=	18.50 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Charmacy Pharmaceutical Co (HKSE:02289) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Charmacy Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

https://www.chmyy.com

Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines